Print Page  |  Close Window

News Release

HeartWare Presentation At The Goldman Sachs 37th Annual Global Healthcare Conference To Be Webcast

FRAMINGHAM, Mass., June 1, 2016 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that members of HeartWare's executive management are scheduled to participate in a webcast session at the Goldman Sachs 37th Annual Global Healthcare Conference on June 8, 2016 at 10:40 a.m. PT (1:40 p.m. ET).  The conference is being held June 7-9 in Rancho Palos Verdes, California.

The live webcast of the company's presentation at the conference will be available via a link provided at  A replay of the webcast will be available for 90 days after the presentation.

About HeartWare International
HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat patients around the world suffering from advanced heart failure.  Dedicated to developing new, minimally invasive technologies to revolutionize the treatment of patients with end-stage heart failure, HeartWare has multiple technologies in development to offer progressively less-invasive mechanical circulatory support options.  HeartWare's corporate headquarters are located in Framingham, Massachusetts, and the company has technology, operations, manufacturing and distribution centers in Miami Lakes, Florida; Arden Hills, Minnesota; and Hannover, Germany.  For additional information about the company, please visit

HeartWare International, Inc. is a member of the Russell 2000®, and its securities are publicly traded on The NASDAQ Stock Market.

HEARTWARE, HVAD, MVAD, PAL, SYNERGY, CIRCULITE and HeartWare logos are trademarks of HeartWare, Inc. or its affiliates.  

For additional information:
Christopher Taylor
HeartWare International, Inc.
Phone: +1 508 739 0864

HeartWare International, Inc.

Logo -


To view the original version on PR Newswire, visit:

SOURCE HeartWare International, Inc.